MarketCap
Facebook
X
Telegram
Timber Pharmaceuticals EV | TMBR
EV Jährlich Timber Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 388 K | -11.9 M | 20 M | 28.9 M | 2.73 B | 2.74 B | 2.48 B | 5.3 B | 8.86 B | 1.74 M | 193 K | -15.6 K | -7 K |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 8.86 B | -11.9 M | 1.7 B |
EV anderer Aktien in der Pharmaeinzelhändler
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Cardiff Oncology
CRDF
|
115 M | $ 0.81 | -10.82 % | $ 54.1 M |  USA |
 |
Inhibrx
INBX
|
1.73 B | $ 88.26 | -5.48 % | $ 4.16 B | USA |
 |
Kazia Therapeutics Limited
KZIA
|
10 M | $ 7.91 | 1.28 % | $ 121 M |  Australia |
 |
Fate Therapeutics
FATE
|
140 M | $ 2.06 | -2.61 % | $ 245 M | USA |
 |
Eton Pharmaceuticals
ETON
|
599 M | $ 50.15 | 0.3 % | $ 1.35 B | USA |
 |
Fulcrum Therapeutics
FULC
|
359 M | $ 3.65 | -0.95 % | $ 231 M | USA |
 |
Hutchison China MediTech Limited
HCM
|
12.4 B | $ 14.31 | -0.38 % | $ 12.3 B |  China |
 |
IDEAYA Biosciences
IDYA
|
2.7 B | $ 33.2 | -4.35 % | $ 2.94 B | USA |
 |
InflaRx N.V.
IFRX
|
60.9 M | $ 1.57 | 0.32 % | $ 106 M |  Germany |
 |
Immutep Limited
IMMP
|
2.92 B | $ 3.07 | -4.06 % | $ 4.47 B | Australia |
 |
XTL Biopharmaceuticals Ltd.
XTLB
|
860 M | $ 1.89 | -6.44 % | $ 1.27 B |  Israel |
 |
Zoetis
ZTS
|
65.9 B | $ 80.89 | -0.17 % | $ 35.9 B | USA |
 |
Kala Pharmaceuticals
KALA
|
-3.43 M | $ 0.19 | -1.95 % | $ 1.55 M | USA |
 |
Mereo BioPharma Group plc
MREO
|
2.03 B | $ 0.28 | -1.99 % | $ 223 M |  Britain |
 |
Kiniksa Pharmaceuticals, Ltd.
KNSA
|
3.31 B | $ 73.0 | -4.87 % | $ 5.42 B | USA |
 |
Karyopharm Therapeutics
KPTI
|
341 M | $ 0.48 | -6.34 % | $ 5.25 K | USA |
 |
MediciNova
MNOV
|
42.4 M | $ 1.41 | 1.44 % | $ 69.2 M | USA |
 |
Seres Therapeutics
MCRB
|
110 M | $ 2.01 | -3.83 % | $ 17.8 M | USA |
 |
MediWound Ltd.
MDWD
|
32 M | $ 12.1 | 0.83 % | $ 329 M | Israel |
 |
SELLAS Life Sciences Group
SLS
|
503 M | $ 11.35 | -1.69 % | $ 1.24 B | USA |
 |
Precigen
PGEN
|
1.07 B | $ 6.05 | -2.34 % | $ 1.89 B | USA |
 |
PolyPid Ltd.
PYPD
|
61.3 M | $ 5.3 | 0.95 % | $ 86.7 M | Israel |
 |
Rocket Pharmaceuticals
RCKT
|
283 M | $ 2.27 | -0.87 % | $ 252 M | USA |
 |
Avidity Biosciences
RNA
|
9.93 B | $ 8.04 | -1.93 % | $ 1.11 B | USA |
 |
Summit Therapeutics
SMMT
|
11.9 B | $ 14.5 | -6.3 % | $ 10.8 B | Britain |
 |
Celsion Corporation
CLSN
|
-3.55 M | - | -6.63 % | $ 13.9 M | USA |
 |
I-Mab
IMAB
|
127 M | - | - | $ 866 M | China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
1.95 B | - | - | $ 40.3 B | USA |
 |
Genfit SA
GNFT
|
168 B | - | 2.54 % | $ 160 B |  France |
 |
Biophytis SA
BPTS
|
174 M | - | -13.47 % | $ 169 M | France |
 |
Scholar Rock Holding Corporation
SRRK
|
4.92 B | $ 41.71 | 0.52 % | $ 4.78 B | USA |
 |
CureVac N.V.
CVAC
|
-376 M | - | - | $ 867 M | Germany |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
686 M | - | 0.74 % | $ 768 M | Israel |
 |
Abcam plc
ABCM
|
5.18 B | - | - | $ 4.9 B | Britain |
 |
Midatech Pharma plc
MTP
|
-1.76 M | - | -18.52 % | $ 27.3 M | Britain |
 |
MorphoSys AG
MOR
|
2.44 B | - | 2.43 % | $ 254 M | Germany |
 |
Affimed N.V.
AFMD
|
-38.5 M | - | -34.95 % | $ 21.5 M | Germany |
 |
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
215 M | - | -1.58 % | $ 28.1 M | China |
 |
Celyad Oncology SA
CYAD
|
-1.83 M | - | - | $ 12.5 M |  Belgium |
 |
Gracell Biotechnologies
GRCL
|
-1.17 B | - | - | $ 3.37 B | China |
 |
Galapagos NV
GLPG
|
1.99 B | - | - | $ 1.83 B | Belgium |
 |
Tiziana Life Sciences PLC
TLSA
|
104 M | $ 0.88 | -7.06 % | $ 93.9 M | Britain |
 |
Teligent, Inc.
TLGT
|
4.75 B | - | -13.85 % | $ 16.1 M | USA |
 |
Viela Bio, Inc.
VIE
|
5.37 B | - | - | $ 2.91 B | USA |
 |
Aphria Inc.
APHA
|
54.3 B | - | -0.45 % | $ 4.87 B |  Canada |
 |
Aerpio Pharmaceuticals, Inc.
ARPO
|
3.74 B | - | -0.90 % | $ 104 M | USA |
 |
Chiasma, Inc.
CHMA
|
19.2 B | - | -6.00 % | $ 238 M | USA |
 |
Adamas Pharmaceuticals, Inc.
ADMS
|
-10.8 M | - | - | $ 376 M | USA |
 |
Cellect Biotechnology Ltd.
APOP
|
1.09 B | - | 0.38 % | $ 12.9 M | Israel |